Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Protecting cancer patients against COVID-19: New strains, new vaccines

Aired live on 23 Mar 2022

ESMO-Webinar-Series-Protecting-Cancer-Patients-1000x250

Protecting cancer patients against COVID-19: New strains, new vaccines

Chair: John Haanen
Speakers: Danny Altmann and Petros Grivas

ESMO-Webinar-Series-Protecting-Cancer-Patients-1000x250

Login to get immediate access to this content.

Login

ESMO Members: Take the CME test

Learning objectives:

  • To provide an updated overview of efficacy and safety of anti-SARS-CoV-2 vaccines in patients with cancer
  • To highlight emerging data on monitoring and enhancing vaccine-induced immunity
  • To highlight therapeutic interventions beyond vaccines for the prevention of severe morbidity and mortality in immunosuppressed or high-risk patients
  • To provide insights in research progress on second generation vaccine development

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.